Smith J. Jefferson's Form 4 filing
Precision Biosciences Inc (DTIL) · filed Jan 23, 2024
- Accession no.
- 0001209191-24-002113
- Filed
- Jan 23, 2024, 7:11 PM ET
- Trade date
- Jan 20-23, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $10.4K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Smith J. JeffersonCIK 0001770169 | Officer (Chief Research Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2024 | Common Stock | MOption exerciseAcquired | +75,015 | – | – | 2,015,269 | Direct | |
| Jan 23, 2024 | Common Stock | SSaleDisposed | −28,000 | $0.37 | −$10,360 | 1,987,269 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2024 | Common Stock | MOption exerciseDisposed | −75,015 | $0.00 | $0 | 149,985 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.